PhaseRx, Inc. (PZRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
PhaseRx Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2017 | -2.572M |
| June 30, 2017 | -3.489M |
| March 31, 2017 | -3.626M |
| December 31, 2016 | -3.134M |
| September 30, 2016 | -2.553M |
| June 30, 2016 | -2.327M |
| Date | Value |
|---|---|
| March 31, 2016 | -1.797M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -1.527M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Athersys, Inc. | -- |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.28M |
| Sarepta Therapeutics, Inc. | 197.07M |